APA (7th ed.) Citation

L, W., N, O., D, S., S, C., V, R., R, P., . . . DG, N. (1985). Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major. The New England journal of medicine, 312(25), 1600. https://doi.org/10.1056/NEJM198506203122503

Chicago Style (17th ed.) Citation

L, Wolfe, Olivieri N, Sallan D, Colan S, Rose V, Propper R, Freedman MH, and Nathan DG. "Prevention of Cardiac Disease by Subcutaneous Deferoxamine in Patients with Thalassemia Major." The New England Journal of Medicine 312, no. 25 (1985): 1600. https://doi.org/10.1056/NEJM198506203122503.

MLA (9th ed.) Citation

L, Wolfe, et al. "Prevention of Cardiac Disease by Subcutaneous Deferoxamine in Patients with Thalassemia Major." The New England Journal of Medicine, vol. 312, no. 25, 1985, p. 1600, https://doi.org/10.1056/NEJM198506203122503.